id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0223-0001,FDA,FDA-2002-D-0223,Guidance for Industry: An Acceptable Circular of Information for the Use of Human Blood and Blood Components - Draft Guidance,Notice,NAD-Notice of Availability of Data,2002-10-21T04:00:00Z,2002,10,2002-10-21T04:00:00Z,2002-12-18T04:59:59Z,2009-12-23T14:56:40Z,,0,0,09000064804971b6